Elevance Health (ELV) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter declined compared to the immediately preceding quarter but rose compared to the same quarter one year earlier. The trailing twelve-month revenue remained above the prior year level.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter declined compared to the immediately preceding quarter but rose compared to the same quarter one year earlier. The trailing twelve-month revenue remained above the prior year level.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$49.7B
Revenue reported for this quarter.
Quarter-over-quarter
-1.9%
Change from the immediately preceding quarter.
Year-over-year
+9.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$199.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $48.9B | +14.8% |
| Jun 30, 2025 | $49.8B | +13.4% |
| Sep 30, 2025 | $50.7B | +12.4% |
| Dec 31, 2025 | $49.7B | +9.5% |
Revenue performance
The reported revenue was lower than the prior quarter, reversing the upward trend seen in earlier periods. Year-over-year, the figure moved higher.
Quarterly comparison
Compared to the preceding quarter, revenue decreased. Compared to the same quarter one year ago, revenue increased.
What to watch
The sequential decline in revenue following a period of growth represents a change in trend that may warrant attention.